NK-modulating CD27 antibodies (HZI/Ascenion)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNK-modulating CD27 antibodies (HZI/Ascenion)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCD27 antigen modulators
TargetsCD27 antigen
Therapy Area/IndicationsVirus DiseasesSepsisBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Zentrum fur Infektionsforschung GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelmholtz Zentrum fur Infektionsforschung GmbHAscenion
Active IndicationsN/A
Inactive IndicationsVirus DiseasesSepsisBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A